natgillin/translations-raw huggingface dataset:
The four major final metabolites are propranolol glucuronide, naphthyloxylactic acid and glucuronic acid, and sulfate conjugates of 4-hydroxy propranolol. 
Štirje glavni končni presnovki so propranolol glukuronid, naftiloksilaktična kislina in glukuronska kislina ter sulfatni konjugati 4-hidroksi propranolola.
• Asthma or history of bronchospasm 
• Astma ali anamneza bronhospazma
Dermatitis psoriasiform 
Psoriaziformni dermatitis
Mean apparent oral clearance was 2.71 L/h/kg in infants aged 65- 120 days and 3.27 L/h/kg in infant aged 181- 240 days. 
Povprečen opažni peroralni očistek je bil 2,71 l/h/kg pri dojenčkih, starih od 65 do 120 dni, in 3,27 l/h/kg pri dojenčkih, starih od 181 do 240 dni.
In adult male rats, repeated administration of propranolol at high dose levels (≥7.5 mg/kg) induced histopathological lesions of the testes, epididymis, and seminal vesicles, decrease in sperm motility, sperm cell concentration, plasma testosterone levels and significant increase in sperm head and tail abnormalities. 
Pri odraslih samcih podgan je ponavljajoče dajanje propranolola z visokimi stopnjami odmerkov (≥ 7,5 mg/kg) povzročilo histopatološke lezije testisov, epididimisa in seminalnih veziklov, zmanjšanje gibljivosti sperme, koncentracije spermijev, nivojev testosterona v plazmi in znatno povečanje nepravilnosti glav in repov spermijev.
If you are breastfeeding your child 
Če otroka dojite
It can aggravate hypoglycaemia in children, especially in case of fasting, vomiting or overdose. 
Pri otrocih lahko poslabša hipoglikemijo, zlasti v primeru posta, bruhanja ali čezmernega odmerka.
Like all medicines, this medicine can cause side effects, although not everybody gets them. 
4 Možni neželeni učinki Kot vsa zdravila ima lahko tudi to zdravilo neželene učinke, ki pa se ne pojavijo pri vseh bolnikih.
4.4 Special warnings and precautions for use 
4.4 Posebna opozorila in previdnosti ukrepi
Propranolol passes through breast milk, mothers being treated with propranolol who breastfeed their infant should inform their health care professional. 
Propranolol prehaja v materino mleko, zato morajo matere, ki se zdravijo s propranololom in dojijo, o tem obvestiti svojega zdravnika.
Treatment with propranolol resulted in a rapid improvement (within 7-14 days) in all patients and resolution of the target haemangioma was observed in 36.4% of patients by 3 months. 
Zdravljenje s propranololom je povzročilo hitro izboljšanje (v 7 do 14 dneh) pri vseh bolnikih, izginotje ciljnega hemangioma pa je bilo opaženo pri
Blood sugar decreases observed during clinical studies were asymptomatic. 
Zmanjšanja koncentracije sladkorja v krvi, opažene med kliničnimi študijami, so bila asimptomatska.
• Citric acid monohydrate 
• citronska kislina monohidrat
Nervous system disorders 
Motnje živčnega sistema
• Bradycardia (abnormally low heart rate), 
• bradikardija (neobičajno počasen srčni utrip),
• a local haemodynamic effect (vasoconstriction which is a classical consequence of beta adrenergic blockade and a decrease of infantile haemangioma lesion perfusion); 
• lokalni hemodinamični učinek (vazokonstrikcija, ki je klasična posledica beta adrenergične blokade, in zmanjšanje prekrvitve lezije infantilnega hemangioma);
Propranolol may increase the risk of stroke in PHACE syndrome patients with severe cerebrovascular anomalies by dropping blood pressure and attenuating flow through occluded, narrow, or stenotic vessels. 
Propranolol lahko poveča tveganje za možgansko kap pri bolnikih s sindromom PHACE s hudimi cerebrovaskularnimi nepravilnostmi zaradi znižanega krvnega tlaka in oslabitve pretoka skozi zamašene, zožene ali stenotične žile.
• Bronchiolitis (inflammation of small bronchi with breathing difficulties and wheeze in the chest, 
• bronhiolitis (vnetje malih dihalnih poti (bronhiolov) s težavami z dihanjem in piskanjem v prsih,
• Bronchospasm (breathing difficulties), 
• bronhospazem (težave z dihanjem),
Bradycardia should be diagnosed if the heart rate declines by more than 30 bpm from baseline. 
Treba je postaviti diagnozo bradikardije, če srčni utrip odstopa za več kot 30 utripov na minuto od izhodiščnega.
Paediatric populations 
Pediatrične populacije
Other medicines and HEMANGIOL 
Druga zdravila in zdravilo HEMANGIOL
A haemangioma is a collection of extra blood vessels that have formed a lump in or under the skin. 
Hemangiom je tvorba dodatnih krvnih žil, ki se oblikujejo v bulo v koži ali pod kožo.
• If your child has psoriasis (a skin condition that produces red, dry plaques of thickened skin), as this medicine may worsen the symptoms of this condition. 
• če ima otrok psoriazo (luskavico - kožna bolezen, pri kateri nastajajo rdeče, suhe ploščice zadebeljene kože), saj to zdravilo poslabša simptome te bolezni.
1 What HEMANGIOL is and what it is used for What HEMANGIOL is 
1 Kaj je zdravilo HEMANGIOL in za kaj ga uporabljamo Kaj je zdravilo HEMANGIOL
Peripheral coldness 
Periferna hladnost
• The dose should always be measured using the oral syringe supplied with the bottle. 
• Odmerek je vedno treba izmeriti s peroralno brizgo, ki je priložena steklenici z zdravilom.
1 bottle of 120 mL and 1 oral syringe. 
peroralna raztopina 1 steklenica s 120 ml in 1 peroralna brizga
• an antiangiogenic effect (decrease of vascular endothelial cells proliferation, reduction of the neovascularization and formation of vascular tubules, reduction of the secretion of Matrix 
• antiangiogenski učinek (zmanjšanje proliferacije vaskularnih endotelnih celic, zmanjšanje neovaskularizacije in tvorbe vaskularnih tubulov, zmanjšanje izločanja matriksne metaloproteinaze 9);
In the event of isolated bronchospasm, treatment must be permanently discontinued. 
V primeru izoliranega bronhospazma je treba zdravljenje trajno prekiniti.
Stop treatment and contact your doctor immediately if after giving HEMANGIOL to your child you observe the following symptoms suggestive of a bronchospasm (temporary restriction of the bronchial tubes that leads to difficulty breathing): cough, quick or difficult breathing or wheezing, associated or not with a bluish-coloured skin. 
Prenehajte z zdravljenjem in takoj obvestite zdravnika, če po uporabi zdravila HEMANGIOL pri otroku opazite naslednje simptome, ki kažejo na bronhospazem (začasna zožitev sapnic, ki povzroča težave z dihanjem): kašelj, hitro ali oteženo dihanje ali piskanje v pljučih, lahko (ne pa nujno) v povezavi z modrikasto kožo.
Wipe the outside dry. 
Zunanjost obrišite do suhega.
• Heart conduction or rhythm disorders (slow or uneven heart beats), 
• motnje prevodnosti srca ali srčnega ritma (počasen ali neenakomeren srčni utrip),
The therapeutic dose is 3 mg/kg/day, which is to be administered into 2 separate doses of 1.5 mg/kg, one in the morning and one in late afternoon, with a time interval of at least 9 hours between two intakes. 
Terapevtski odmerek je 3 mg/kg/dan, ki ga je treba dajati v 2 ločenih odmerkih po 1,5 mg/kg, enega zjutraj in drugega pozno popoldan, med obema vnosoma pa mora miniti vsaj 9 ur.
Pack size: carton containing 1 bottle and 1 oral syringe. 
Velikost pakiranja: škatla vsebuje 1 steklenico in 1 peroralno brizgo.
In particular, in case you are breastfeeding, tell your doctor or pharmacist if you are or if your child is taking: 
Zlasti povejte zdravniku ali farmacevtu, če jemljete vi (v primeru dojenja) ali vaš otrok:
• Convulsions (fits) linked to hypoglycaemia (abnormally low blood sugar levels), 
• krči, povezani s hipoglikemijo (neobičajno nizke revni sladkorja v krvi),
PIERRE FABRE DERMATOLOGIE 45 Place Abel Gance 92100 BOULOGNE FRANCE 
PIERRE FABRE DERMATOLOGIE 45 Place Abel Gance 92100 BOULOGNE FRANCIJA
Infants with large facial infantile hemangioma should be thoroughly investigated for potential arteriopathy associated with PHACE syndrome, with magnetic resonance angiography of the head and neck and cardiac imaging to include the aortic arch, prior to considering propranolol therapy. 
Dojenčke z velikim obraznim infantilnim hemangiomom je treba pred zdravljenjem s propranololom temeljito preiskati glede morebitne arteriopatije, povezane s sindromom PHACE, z magnetno resonančno angiografijo glave in vratu ter s slikanjem srca, ki vključuje aortni lok.
• has a heart problem (such as disorders of the heart rhythm and heart failure. 
• srčne težave (npr. motnje srčnega ritma in srčno popuščanje).
• If your child has a PHACE syndrome (a condition combining haemangioma and vascular abnormalities including cerebral blood vessels), as this medicine may increase the risk of cerebral stroke. 
• če ima vaš otrok sindrom PHACE (bolezen, ki vključuje hemangiom in žilne nepravilnosti, vključno s cerebralnimi krvnimi žilami), saj lahko to zdravilo poveča tveganje možganske kapi.
All beta-blocking agents can mask certain symptoms of hypoglycaemia: palpitations and tachycardia. 
Vsi antagonisti adrenergičnih receptorjev beta lahko zakrijejo določene simptome hipoglikemije: palpitacije in tahikardijo.
Medicinal products inducing orthostatic hypotension Medicinal products that induce postural hypotension (nitrates derivatives, type 5-phosphodiesterase inhibitors, tricyclic antidepressants, antipsychotics, dopaminergic agonists, levodopa, amifostine, baclofen…) may add their effects to that of beta-blockers. 
Zdravila, ki inducirajo posturalno hipotenzijo (nitratni derivati, zaviralci fosfodiesteraze tipa 5, triciklični antidepresivi, antipsihotiki, dopaminergični agonisti, levodopa, amifostin, baklofen...) lahko dodajo svoj učinek k učinku antagonistov adrenergičnih receptorjev beta.
In case of acute broncho-pulmonary abnormality, the initiation of the treatment should be postponed. 
V primeru akutne bronhopulmonalne nepravilnosti je treba začetek zdravljenja odložiti.
With regard to centrally-acting antihypertensives, betablockers may exacerbate the rebound hypertension after clonidine abrupt withdrawal, and propranolol should be stopped several days before discontinuing clonidine. 
Kar zadeva centralno delujoče antihipertenzive, antagonisti adrenergičnih receptorjev beta poslabšajo povratno hipertenzijo po nenadni prekinitvi jemanja klonidina, propranolol je zato treba prenehati jemati nekaj dni pred prenehanjem jemanja klonidina.
• The active substance is propranolol. 
• Učinkovina je propranolol.
Their frequency is defined using the following conventions: very common (≥ 1/10), common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000 to < 1/100); rare (≥ 1/10,000 to < 1/1,000); very rare (< 1/10,000); not known (cannot be estimated from the available data). 
< 1/10); občasni (≥ 1/1.000 do < 1/100); redki (≥ 1/10.000 do < 1/1.000); zelo redki (< 1/10.000);
• The other ingredients are hydroxyethylcellulose, sodium saccharin, strawberry flavour (contains propylene glycol), vanilla flavour (contains propylene glycol), citric acid monohydrate, purified water. 
• Druge sestavine zdravila so hidroksietilceluloza, natrijev saharin, aroma jagode (vsebuje propilenglikol), aroma vanilje (vsebuje propilenglikol), citronska kislina monohidrat, prečiščena voda.
Isoproterenol and aminophylline may be used for bronchospasm. 
Za bronhospazem se lahko uporabljata izoproterenol in aminofilin.
Beta-blockers will result in an attenuation of reflex tachycardia and an increased risk of hypotension. 
Antagonisti adrenergičnih receptorjev beta bodo povzročili atenuacijo refleksne tahikardije in povečano tveganje hipotenzije.
The regimen 3 mg/kg/day during 6 months (selected at the end of the phase II part of the study) presented 60.4% of success versus 3.6% in the placebo arm (p value < 0.0001). 
faze študije) je bil uspešen v 60,4 % v primerjavi s 3,6-odstotnim uspehom pri placebu (vrednost p < 0,0001).
Dose by intake Timing of intakes 
Odmerek na vnos Časovni razpored vnosov
In adult female rats, propranolol given into the uterus or by intravaginal administration is a powerful anti-implantation agent at dose ≥4 mg per animal, the effects being reversible. 
Pri odraslih samicah podgan je propranolol, dan v maternico ali prek intravaginalnega dajanja, močno sredstvo proti implantaciji pri odmerku ≥4 mg na žival, učinki pa so reverzibilni.
• Medicines for diabetes, 
• zdravila za sladkorno bolezen,
Check the HEMANGIOL dose in milligrams (mg) as prescribed by your doctor. 
• 2. korak: Preverite odmerek Preverite odmerek zdravila HEMANGIOL v miligramih (mg), kot je predpisal zdravnik.
Bradycardia is defined below the following limits: 
Bradikardija je definirana pod naslednjimi mejami: Starost
However, several reports of hypoglycaemia with related hypoglycaemic seizure were reported during the compassionate use program and in literature, especially in case of fasting period during intercurrent illness (see section 
Vseeno pa so poročali o nekaj primerih hipoglikemije s povezanim hipoglikemičnim napadom med programom sočutne uporabe in v literaturi, zlasti v primeru obdobja posta med sočasno boleznijo
• The metabolism of propranolol is reduced by co-administration of quinidine, leading to a twothree-fold increased blood concentration and greater degrees of clinical beta-blockade. 
• Presnovo propranolola zmanjšuje sočasna uporaba kinidina, ki povzroči od dva- do trikratno povečanje koncentracije v krvi in višje stopnje kliničnih beta blokad.
Patients with infantile haemangioma may be at increased risk if they have received or are concomitantly receiving treatment with corticosteroids because adrenal suppression may result in loss of the counterregulatory cortisol response and increase the risk of hypoglycaemia. 
Pri bolnikih z infantilnim hemangiomom je morda povečano tveganje, če so bili zdravljeni ali se sočasno zdravijo s kortikosteroidi, saj lahko supresija nadledvične žleze privede do izgube protiregulatornega odziva na kortizol in poveča tveganje hipoglikemije.
In patients likely to experience severe anaphylactic reaction, regardless of origin, particularly with iodinated contrast agents, beta-blocker treatment may lead to worsening of the reaction and resistance to its treatment with adrenaline at normal doses. 
Pri bolnikih, pri katerih obstaja verjetnost hude anafilaktične reakcije ne glede na izvor, zlasti pri uporabi jodiranih kontrastnih sredstev, lahko zdravljenje z antagonisti adrenergičnih receptorjev beta privede do poslabšanja reakcije in odpornosti na zdravljenje z adrenalinom v običajnih odmerkih.
• Sodium saccharin 
• natrijev saharinat
Globally, the adverse reactions reported in the compassionate use program and in literature concerned hypoglycemia (and related event like hypoglycaemic seizure) and aggravated respiratory tract infections with respiratory distress. 
Globalno so bili neželeni učinki, o katerih so poročali v programu sočutne uporabe in v literaturnih podatkih, hipoglikemija (in povezani dogodki, kot so hipoglikemične konvulzije) in poslabšanje okužbe dihal z dihalno stisko.
Mortality with unknown although unlikely relationship to treatment was observed at 40 mg/kg/day, leading to a NOAEL of 20 mg/kg/day for juvenile toxicity. 
Smrtnost z neznano, čeprav malo verjetno povezanostjo z zdravljenjem je bila opažena pri odmerkih 40 mg/kg/dan, zaradi česar se za vrednost NOAEL za toksičnost za juvenilne živali smatra
• HEMANGIOL and the feed must be given by the same person in order to avoid the risk of hypoglycaemia. 
• Zdravilo HEMANGIOL in hrano mora dati ista oseba, da se prepreči tveganje hipoglikemije.
- For bradycardia and hypotension: fatigue, coldness, pallor, bluish-coloured skin, and fainting. 
- Za bradikardijo in hipotenzijo: utrujenost, hladnost, bledica, modrikasta koža in nezavest.
4 CLINICAL PARTICULARS 4.1 Therapeutic indications 
4.1 Terapevtske indikacije
• Decreased blood sugar levels, 
• znižana raven sladkorja v krvi,
Propranolol, due to its pharmacological action, may cause or worsen bradycardia or blood pressure abnormalities. 
Propranolol lahko zaradi svojega farmakološkega učinkovanja povzroči ali poslabša bradikardijo ali nepravilnosti krvnega tlaka.
• The metabolism of intravenous lidocaine is inhibited by co-administration of propranolol, resulting in a 25% increase in lidocaine concentrations. 
• Presnovo intravenoznega lidokaina zavira sočasna uporaba propranolola, posledica pa je 25odstotno povečanje koncentracije lidokaina.
• has a high blood pressure caused by a tumour on the adrenal gland. 
• visok krvni tlak, ki ga povzroča tumor nadledvične žleze.
Discard the syringe once the bottle is finished. 
Odvrzite brizgo, potem ko izpraznite steklenico.
Blood levels of propranolol may be decreased by co-administration of enzyme inducers like rifampicin or phenobarbital. 
Induktorji encimov Koncentracije propranolola v krvi se lahko znižajo ob sočasni uporabi induktorjev encimov, kot sta rifampicin ali fenobarbital.
Duration of treatment: 
Trajanje zdravljenja
Replace the plastic cap on the bottle by turning it clock-wise (to the right). 
Namestite plastični pokrovček na steklenico, tako da ga zavrtite v smeri urnega kazalca (v desno).
In the event of lower respiratory tract infection associated with dyspnoea and wheezing, treatment should be temporarily discontinued. 
V primeru okužbe spodnjih dihalnih poti, povezane z dispnejo in piskanjem v pljučih, je treba zdravljenje začasno prekiniti.
This medicine contains 2.08 mg of propylene glycol/kg/day. 
To zdravilo vsebuje 2,08 mg propilenglikola/kg/dan.
In the absence of data in children, propranolol is not recommended in case of renal or hepatic impairment (see section 4.2). 
Zaradi pomanjkanja podatkov pri otrocih ne priporočamo propranolola v primeru motenj delovanja ledvic ali jeter (glejte poglavje 4.2).
The advice of a cardiologist should be sought. 
Posvetujte se s kardiologom.
If clinical signs of hypoglycaemia occur, it is necessary to make the child drink a sugary liquid solution and to temporarily stop the treatment. 
Če se pojavijo klinični znaki hipoglikemije, mora otrok piti sladko raztopino in je zdravljenje treba začasno prekiniti.
HEMANGIOL contains sodium and propylene glycol 
Zdravilo HEMANGIOL vsebuje natrij in propilenglikol
9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION 
9 DATUM PRIDOBITVE/PODALJŠANJA DOVOLJENJA ZA PROMET Z ZDRAVILOM
Tell the your doctor that he/she is taking HEMANGIOL. 
Povejte svojemu zdravniku, da otrok jemlje zdravilo HEMANGIOL.
HEMANGIOL should be administered directly into the child's mouth using the graduated oral syringe, calibrated in mg of propranolol base, supplied with the oral solution bottle (see instructions for use in section 3 of the patient information leaflet). 
Zdravilo HEMANGIOL se daje neposredno v otrokova usta z uporabo graduirane brizge za peroralno dajanje, umerjene v miligramih propranolola, ki je priložena steklenici s peroralno raztopino (glejte navodila za uporabo v poglavju 3 navodil za uporabo).
In terms of reproductive development, growth and neurological development there were no propranolol-related effects or toxicologically significant findings at 40 mg/kg/day, correlating to safety margins of 1.2 in females and 2.9 in males, based on mean propranolol exposures on PND 21. 
povezanih z propranololom, ali toksikološko pomembnih ugotovitev pri 40 mg/kg/dan, kar ustreza varnostni meji 1,2 pri samicah in 2,9 pri samcih, na osnovi povprečne izpostavljenosti propranololu na PND 21.
Third and following weeks (3 mg/kg/day) 
Tretji teden in nadaljnji tedni (3 mg/kg/dan)
• has very low blood pressure. 
• zelo nizek krvni tlak.
• Bronchitis (inflammation of the bronchi), 
• bronhitis (vnetje sapnic (bronhijev)),
Heart rate (beats/min) 
Srčni utrip (udarci/min) 100
HEMANGIOL may increase potassium blood level (hyperkaliemia). 
Tveganje za hiperkaliemijo Zdravilo HEMANGIOL lahko poveča raven kalija v krvi (hiperkaliemija).
Interactions requiring precautions for use 
Medsebojna delovanja, ki zahtevajo previdnostne ukrepe pri uporabi Kardiovaskularna zdravila
Clear, colourless to slightly yellow oral solution, with a fruity odour. 
Prozorna, brezbarvna do rahlo rumena peroralna raztopina s sadnim vonjem.
Lidocaine toxicity (neurological and cardiac adverse events) has been reported following co-administration with propranolol. 
Poročali so o toksičnosti lidokaina (nevrološki in srčni neželeni dogodki) zaradi sočasne uporabe s propranololom.
• Give HEMANGIOL directly into your child's mouth using the oral syringe supplied with the bottle. 
• Zdravilo HEMANGIOL dajte neposredno v otrokova usta z uporabo peroralne brizge, ki je priložena steklenici.
Isolated cases of symptomatic bradycardia and hypotension have been reported in literature. 
V literaturi so poročali o izoliranih primerih simptomatične bradikardije in hipotenzije.
Infants with hepatic or renal impairment 
Dojenčki z motnjami delovanja jeter ali ledvic
Sympathetic stimulation may be a vital component supporting circulatory function in patients with congestive heart failure, and its inhibition by beta blockade may precipitate more severe failure. 
Simpatična stimulacija je morda bistvena komponenta za podporo delovanju ožilja pri bolnikih s kongestivnim srčnim popuščanjem, njeno zaviranje z antagonisti adrenergičnih receptorjev beta pa lahko izzove še hujšo okvaro.
The readministration of propranolol may be considered when the child has fully recovered; in case of reoccurrence, treatment should be permanently discontinued. 
S ponovnim dajanjem propranolola lahko nadaljujemo, ko otrok popolnoma ozdravi; če se znova pojavi,
• HEMANGIOL is a clear, colourless to slightly yellow oral solution, with a fruity odour. 
• Zdravilo HEMANGIOL je prozorna, brezbarvna do rahlo rumena peroralna raztopina s sadnim vonjem.
Do not dismantle the syringe. 
Brizge ne razstavljajte.
Propranolol belongs to a group of medicines known as beta-blockers. 
Propranolol spada v skupino zdravil, znanih kot antagonisti adrenergičnih receptorjev beta.
The occurrence of diarrhea seems to be dose-dependent between 1 and 3 mg/kg/day. 
Pojav driske je morebiti odvisen od odmerka med 1 in 3 mg/kg/dan.
In clinical trials for proliferating infantile haemangioma, the most frequently reported adverse reactions in infant treated with HEMANGIOL were sleep disorders (16.7%), aggravated respiratory tract infections such as bronchitis and bronchiolitis associated with cough and fever, diarrhoea (16.5%), and vomiting (11.5%). 
Pri kliničnih preizkušanjih hitro rastočega infantilnega hemangioma so bili neželeni učinki, o katerih so največkrat poročali pri dojenčkih, zdravljenih z zdravilom HEMANGIOL, motnje spanja (16,7 %), poslabšanje okužb dihalnih poti, kot sta bronhitis in bronhiolitis, povezana s kašljem in z vročino,
The treatment of your child has been initiated by a physician who has expertise in the diagnosis, treatment and management of infantile haemangioma. 
3 Kako otroku dajati zdravilo HEMANGIOL Z zdravljenjem vašega otroka je začel zdravnik, ki je strokovnjak za diagnosticiranje, zdravljenje in ravnanje z infantilnim hemangiomom.
In the absence of data, administration of the medicinal product is not recommended to infants with hepatic or renal impairment (see section 4.4). 
Zaradi pomanjkanja podatkov dajanje zdravila ni priporočljivo za dojenčke z motnjami delovanja jeter ali ledvic (glejte poglavje 4.4).
Both digitalis glycosides and beta-blockers slow atrioventricular conduction and decrease heart rate. 
Tako glikozidi digitalisa kot antagonisti adrenergičnih receptorjev beta upočasnjujejo atrioventrikularno prevajanje in zmanjšujejo srčni utrip.
Hyperkaliemia cases have been reported in patients with large ulcerated hemangioma. 
Obstajajo primeri hiperkaliemije pri bolnikih z velikim ulceriranim hemangiomom.
• It is supplied in a 120-mL amber glass bottle, with a child resistant screw-cap. 
• Zdravilo je na voljo v 120-ml rjavorumeni steklenici s pokrovčkom, ki ga otroci ne morejo odpreti.
Second week (2 mg/kg/day) 
Drugi teden (2 mg/kg/dan)
What HEMANGIOL looks like and contents of the pack 
Izgled zdravila HEMANGIOL in vsebina pakiranja
10, rue Bouché Thomas ZAC d'Orgemont F-49000 Angers France 
ZAC d'Orgemont F-49000 Angers Francija